Search Results - "Boland, Greet J."

Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials by Doedée, Anne M C M, Boland, Greet J, Pennings, Jeroen L A, de Klerk, Arja, Berbers, Guy A M, van der Klis, Fiona R M, de Melker, Hester E, van Loveren, Henk, Janssen, Riny

“…Worldwide, paracetamol is administered as a remedy for complaints that occur after vaccination. Recently published results indicate that paracetamol inhibits…”
Get full text

Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants by MEIJER, Ellen, BOLAND, Greet J, VERDONCK, Leo F

“…Classifications Services CMR Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection by Lieveld, Faydra I, Swaans, Niels, Newsum, Astrid M, Ho, Cynthia K.Y, Schinkel, Janke, Molenkamp, Richard, van der Meer, Jan T.M, Arends, Joop E, Hoepelman, Andy I.M, Wensing, Anne M.J, Siersema, Peter D, Erpecum, Karel J. van, Boland, Greet J

“…AbstractBackground and aim. Resistance-associated variants (RAVs) on the NS3 region of the hepatitis C virus (HCV) may be relevant for antiviral therapy, but…”
Get full text

Assessing and improving the quality of guideline-adherent hepatitis B virus care in people with HIV: A cross-sectional study by Oomen, Patrick Ga, van Kraaij, Vincent Jp, Gerritsma, Anna M, Verduyn Lunel, Frans M, Boland, Greet J, Hoepelman, Andy Im, van Welzen, Berend J

“…The increasing use of non-tenofovir containing antiretroviral regimens calls for renewed attention to the prevention and management of hepatitis B virus (HBV)…”
Get more information

A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region by Png, Eileen, Thalamuthu, Anbupalam, Ong, Rick T.H., Snippe, Harm, Boland, Greet J., Seielstad, Mark

“…We performed a two-stage genome-wide association study (GWAS) of antibody titer in 3614 hepatitis B vaccine recipients from Indonesia's Riau Archipelago,…”
Get full text

REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro‐elimination in the Utrecht province by Kracht, Patricia A. M., Arends, Joop E., van Erpecum, Karel J., Thijsen, Steven F. T., Vlaminckx, Bart J. M., Weersink, Annemarie J. L., Wensing, Anne M. J., Deege, Marjolein P. H., Dimmendaal, Marieke, Stadhouders, Paul H. G. M., Friederich, Philip W., Verhagen, Marc A. M. T., Boland, Greet J., Hoepelman, Andy I. M.

“…Background The Netherlands is one of the six European countries considered on track to eliminate hepatitis C virus by 2030. To achieve this goal, continuous…”
Get full text

Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection by Gouma, Sigrid, ten Hulscher, Hinke I, Schurink-van ’t Klooster, Tessa M, de Melker, Hester E, Boland, Greet J, Kaaijk, Patricia, van Els, Cécile A.C.M, Koopmans, Marion P.G, van Binnendijk, Rob S

“…Highlights • Correlation between mumps IgG concentrations and mumps neutralization is poor. • Prior to mumps infection neutralization of genotype G mumps virus…”
Get full text

The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands by Newsum, Astrid M, Ho, Cynthia K.Y, Lieveld, Faydra I, van de Laar, Thijs J.W, Koekkoek, Sylvie M, Rebers, Sjoerd P, van der Meer, Jan T.M, Wensing, Anne M.J, Boland, Greet J, Arends, Joop E, van Erpecum, Karel J, Prins, Maria, Molenkamp, Richard, Schinkel, Janke

“…OBJECTIVES:The Q80K polymorphism is a naturally occurring resistance-associated variant in the hepatitis C virus (HCV) nonstructural protein 3 (NS3) region and…”
Get full text

Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence by Stoof, Susanne P, van Ravenhorst, Mariëtte B, van Rooijen, Debbie M, de Voer, Richarda M, van der Klis, Fiona R M, Boland, Greet J, Sanders, Elisabeth A M, Berbers, Guy A M, Teunis, Peter F

“…Adolescent vaccination is now considered the key factor for offering direct protection against meningococcal disease but also for reducing carriage and…”
Get full text

Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara® ) by Roukens, Anna H, Vossen, Ann C, Boland, Greet J, Verduyn, Willem, van Dissel, Jaap T, Visser, Leo G

“…Abstract Trial registration: NTR1043 ( http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1043 ). Background Five to ten percent of immunocompetent…”
Get full text

No influence of haemodialysis on interferon production in the QuantiFERON-TB Gold-In-Tube test by Hoogewerf, Martine, Boland, Greet J, Hoepelman, Andy I M, Boer, Walther H, Mudrikova, Tania

“…Immunodeficiency in end-stage renal disease (ESRD) can be aggravated by haemodialysis (HD). This results in an increased incidence of reactivation of…”
Get more information

Measuring Ribavirin Concentrations During the Earliest Stages of Antiviral Therapy for Hepatitis C: Potential Relevance for Treatment Outcome by VAN VLERKEN, Lotte G, DE KANTER, Clara T. M. M, BOLAND, Greet J, VAN LOON, Anton M, VAN SOEST, Hanneke, KOEK, Ger H, DRENTH, Joost P. H, SIERSEMA, Peter D, VAN ERPECUM, Karel J, BURGER, David M

“…Correlations between ribavirin (RBV) concentrations and sustained virological response (SVR) to hepatitis C virus treatment have been demonstrated previously…”
Get full text

Mumps Serum Antibody Levels Before and After an Outbreak to Assess Infection and Immunity in Vaccinated Students by Gouma, Sigrid, Schurink-van't Klooster, Tessa M., de Melker, Hester E., Kerkhof, Jeroen, Smits, Gaby P., Hahné, Susan J. M., van Els, Cécile A. C. M., Boland, Greet J., Vossen, Ann C. T. M., Goswami, Pulak R., Koopmans, Marion P. G., van Binnendijk, Rob S.

“…Background.  Since 2009, various mumps outbreaks have occurred in the Netherlands, affecting mostly young adults vaccinated against mumps. In this…”
Get full text

No beneficial effects of amantadine in treatment of chronic hepatitis C patients by van Soest, Hanneke, van der Schaar, Peter J, Koek, Ger H, de Vries, Richard A, van Ooteghem, Nancy A, van Hoek, Bart, Drenth, Joost P.H, Vrolijk, Jan M, Lieverse, Rob J, Houben, Peter, van der Sluys Veer, Annet, Siersema, Peter D, Schipper, Marguerite E.I, van Erpecum, Karel J, Boland, Greet J

“…Abstract Background Benefit of adding amantadine to antiviral therapy for hepatitis C is controversial. Aims We aimed to examine whether such policy enhances…”
Get full text

Cytokine Polymorphisms Play a Role in Susceptibility to Ultraviolet B-Induced Modulation of Immune Responses after Hepatitis B Vaccination by Sleijffers, Annemarie, Yucesoy, Berran, Kashon, Michael, Garssen, Johan, De Gruijl, Frank R, Boland, Greet J, Van Hattum, Jan, Luster, Michael I, Van Loveren, Henk

“…UVB exposure can alter immune responses in experimental animals and humans. In an earlier human volunteer study, we demonstrated that hepatitis B-specific…”
Get full text

Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment by Van Vlerken, Lotte G, Van Soest, Hanneke, Janssen, Mart P, Boland, Greet J, Drenth, Joost P.H, Burger, David M, Siersema, Peter D, Van Erpecum, Karel J

“…BACKGROUNDDuring the treatment of hepatitis C, anaemia may necessitate pegylated-interferon and ribavirin dose reductions with reduced sustained viral response…”
Get full text

T1982 Ribavirin- Rather Than PEG-Interferon-Related Factors are Predicting Non-Response to Antiviral Therapy in Naive Chronic Hepatitis C Patients by van Vlerken, Lotte G, Huisman, Ellen J, van Soest, Hanneke, Boland, Greet J, Siersema, Peter D, Burger, David M, Van Erpecum, Karel J

Get full text

T1984 Influence of Ribavirin on Hepatitis C (HCV) Viral Kinetics at Various Time Points During PEG-Interferon and Ribavirin Treatment in Naive Hepatitis C Patients by Boland, Greet J, van Vlerken, Lotte G, van Soest, Hanneke, Burger, David M, Siersema, Peter D, van Loon, Anton M, Van Erpecum, Karel J

Get full text

T1983 Endogenous Erythropoietin Response and Predictive Factors for Anemia During Treatment With PEG-Interferon Alfa-2B and Ribavirin in Chronic Hepatitis C Patients by van Vlerken, Lotte G, van Soest, Hanneke, Janssen, Mart P, Boland, Greet J, Drenth, Joost PH, Burger, David M, Siersema, Peter D, Van Erpecum, Karel J

Get full text

Occupational blood exposure accidents in the Netherlands by van Wijk, Paul Th. L., Schneeberger, Peter M., Heimeriks, Karin, Boland, Greet J., Karagiannis, Ioannis, Geraedts, Jacques, Ruijs, Wilhelmina L. M.

“…Background: To make proper evaluation of prevention policies possible, data on the incidence and associated medical costs of occupational blood exposure…”
Get full text